[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"fungal-infections\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:fungal-infections":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":4,"leadSponsor":40,"locationsCount":43},"100149894","studies-of-disorders-with-increased-susceptibility-to-fungal-infections-100149894",false,"NCT01222741","Studies of Disorders With Increased Susceptibility to Fungal Infections","* INCLUSION CRITERIA:\n\nPatients\n\nTo be eligible to participate in this study as a patient, an individual must meet the following criteria:\n\n* Be 2 years of age to be seen at the Clinical Center as an outpatient. Children \\\u003C=3 years of age must not have severe infections, as assessed by the investigator, to be seen at the Clinical Center. Send-in samples may be submitted by participants \\>30 days of age.\n* Have an abnormality of immune function as manifested by recurrent or unusual fungal infections, recurrent or chronic inflammation, or previous laboratory evidence of immune dysfunction. Of particular focus of this study are patients with:\n\n  * APECED\n  * CMC\n  * MPO\n  * IPEX\n  * Hyper-immunoglobulin E syndrome (Job s syndrome)\n  * CGD\n  * Biotinidase deficiency\n  * IKAROS defects\n  * AIOLOS defects\n  * IRF4 defects\n  * Other conditions showing increased susceptibility to such infections as described in infants and type 1 diabetic patients\n* Have a primary physician outside of the NIH.\n* Agree to have blood stored for future research.\n* Ability of subject or Legally Authorized Representative (LAR) to understand and the willingness to sign a written informed consent document.\n\nRelatives\n\nTo be eligible to participate in this study as a relative, an individual must meet the following criteria:\n\n* Be 2 years of age to be seen at the Clinical Center as an outpatient. Children \\\u003C=3 years of age must not have severe infections, as assessed by the investigator, to be seen at the Clinical Center. Send-in samples may be submitted for participants \\>30 days of age.\n* Be a mother, father, sibling, child, grandparent, aunt, uncle, or first cousin to a patient participant.\n* Adult relatives must be able to provide informed consent.\n* Agree to have blood stored for future research.\n\nHealthy volunteers\n\nTo be eligible to participate in this study as a healthy volunteer, an individual must meet the following criteria:\n\n* Be 18 to 85 years old.\n* Have a hemoglobin count of \\>11 g\u002FdL.\n* Weigh \\>=110 pounds.\n* Be able to provide informed consent.\n* Be willing to have blood stored for future research.\n\nEXCLUSION CRITERIA:\n\nPatients and Relatives\n\nIn general, there are no strict exclusion criteria for these cohorts. However, the presence of certain types of acquired abnormalities of immunity solely due to HIV, chemotherapeutic agent(s), or an underlying malignancy could be grounds for possible exclusion for a patient or relative. In the opinion of the investigator, the presence of such disease processes may interfere with evaluation of a co-existing abnormality of immunity that is the subject of study under this protocol. Pregnant females will not be allowed to participate in any procedure that may be dangerous to the pregnancy or the fetus.\n\nHealthy volunteers\n\nAn individual who meets any of the following criteria will be excluded from participation as a healthy volunteer in this study:\n\n* Is receiving chemotherapeutic agent(s) or has an underlying malignancy.\n* Is pregnant.\n* Has a history of heart, lung, or kidney disease, or bleeding disorders.\n* Has HIV or viral hepatitis (B or C), or history of viral hepatitis B or C since age 11.",true,"ALL","18 Years","85 Years",{"count":20,"type":21},850,"ESTIMATED","OBSERVATIONAL","Background:\n\n\\- Researchers are interested in studying disorders that make individuals more susceptible to fungal infections, specifically infections with the Candida yeast. These disorders are often related to problems with the immune system and may have genetic factors, which suggests that researchers should study not only the individual with the disorder, but also his or her first- and second-degree relatives (such as parents, siblings, children, and first cousins). To provide material for future research, individuals with immune disorders and their first- and second-degree relatives will be asked to provide blood and other samples for testing and comparison with samples taken from healthy volunteers with no history of immune disorders.\n\nObjectives:\n\n\\- To collect blood and other biological samples to study immune disorders that make individuals more susceptible to fungal infections.\n\nEligibility:\n\n* Individuals of any age who have abnormal immune function characterized by recurrent or unusual fungal infections, recurrent or chronic inflammation, or other types of immune dysfunction.\n* First- or second-degree genetically related family members (limited to mother, father, siblings, grandparents, children, aunts, uncles, and first cousins).\n* Healthy volunteers at least 18 years of age (for comparison purposes).\n\nDesign:\n\n* Participants will provide blood samples and buccal (cells from the inside of the mouth near the cheek) samples.\n* Participants with immune disorders will also be asked to provide urine samples, saliva or mucosal samples, or skin tissue biopsies, and may also have imaging studies (such as x-rays) to collect information for research.\n* Samples may be collected at the National Institutes of Health or at other clinical locations for the samples to the sent to the National Institutes of Health.\n* No treatment will be provided as part of this protocol.",[25,26],"Fungal Infections","Primary Immune Deficiencies",[28,26,29,30,31,32],"PID","Candida","Immune Abnormalities","Diabetic","Natural History","RECRUITING","2026-06-23",{"date":36,"type":37},"2026-06-24","ACTUAL",{"date":39,"type":37},"2011-01-07",{"name":41,"class":42},"National Institute of Allergy and Infectious Diseases (NIAID)","NIH",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":51,"enrollmentInfo":52,"targetDuration":54,"studyType":22,"phases":4,"briefSummary":55,"conditions":56,"keywords":64,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":43},"100465142","emergency-pwas-in-respiratory-infectious-disease-100465142","NCT05336851","Emergency PWAS in Respiratory Infectious Disease","Emergency PanorOmic Wide Association Study in Respiratory Infectious Disease (ePWAS-RID)","Inclusion Criteria:\n\nPatients eligible for enrolment include:\n\nWith reference to previous inclusion criteria are:\n\n* Adults ≥18 years of age; AND\n* Suspected, acute, community-acquired, respiratory, infectious disease (scaRID)\\*; AND\n* Informed consent.\n\nNote: scaRID is defined according to ALL three criteria:\n\n1. Community acquired (not hospitalised for \\\u003C28 days); AND\n2. Acute infection (defined as symptom onset \\\u003C8 days and any ONE of reported fever or chills or aural temperature \\>37.5°C or hypothermia or leucocytosis or leucopaenia or new altered mental status); AND\n3. Probable respiratory infection - According to any ONE of:\n\n   1. new cough or new sputum production or\n   2. chest pain or\n   3. dyspnoea or\n   4. tachypnoea or\n   5. abnormal lung examination or\n   6. respiratory failure; or\n   7. physician's judgment (presenting with systemic or gastrointestinal symptoms).\n\nControl subjects will be drawn from two groups:\n\n* The worried well - adult patients with a National Early Warning Score (NEWS) \\\u003C3 and a temperature \\\u003C37.5°C.\n* Relatives or accompanying friends with no acute illness.\n\nExclusion Criteria:\n\n* Refusal of consent;\n* Recent hospitalisation (\\\u003C28 days);\n* Enrolled in another clinical trial\n* Cellulitis;\n* Skin or orthopaedic infections;\n* Urinary tract infection;\n* Acute abdominal sepsis;\n* Sexual transmitted disease;\n* Human immunodeficiency virus (HIV) infection;\n* Immunocompromised\u002Fpotential neutropenic fever;\n* Solid organ or haematopoietic stem-cell transplant within the previous 90 days;\n* Active graft-versus-host disease or bronchiolitis obliterans;\n* Severe traveller's disease requiring urgent hospitalisation and management including malaria, dengue, typhoid and other rickettsial diseases;\n* Stroke;\n* Toxidrome;\n* Non-organic acute psychosis.","100 Years",{"count":53,"type":21},2000,"1 Year","Develop an emergency PanorOmics Wide Association Study (ePWAS) for the early, rapid biological and pathophysiological characterisation of known and novel Infectious Diseases in adult patients presenting to emergency departments with suspected, acute, community-acquired respiratory infectious disease (scaRID).\n\nPhase 1\n\n1. Develop an ED-ID biobank (named ePWAS-RID). Phase 2\n2. Targeted research for the discovery of novel diagnostics, prognostics and therapeutics",[57,58,25,59,60,61,62,63],"Viral Infections","Bacterial Infections","Mixed Infection","Mycobacterium Infection","Infection of Uncertain Aetiology","Pneumonia","Sepsis",[65,66,67,68,69],"Biobank","Diagnostics and Prognostics","Emergency Medicine","Multiomics and Panoromics","Respiratory Infectious Disease","2026-05-07",{"date":72,"type":37},"2026-05-12",{"date":74,"type":37},"2023-04-11",{"date":76,"type":21},"2028-05-01",{"name":78,"class":79},"The University of Hong Kong","OTHER"]